Integrin inhibitor, Cilengitide trifluoroacetate, Purity ≥98%

Cat. No.: X24-08-YM282

Integrin inhibitor, Cilengitide trifluoroacetate, Purity ≥98%

Synonym: 199807-35-7; EMD 12197; EMD-85189; EMD-121974; NSC-707544; D03497; 2-[(2S,5R,8S,11S)-5-Benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid; 2,2,2-trifluoroacetic acid

  • MDL: MFCD22665738
  • CAS Number: 199807-35-7
  • Compound CID: 129626550
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Cilengitide trifluoroacetate, soluble in DMSO and water and insoluble in ethanol, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin. It targets the αvβ3 receptor (cell-free assay) and αvβ5 receptor (cell-free assay).
Molecular Weight
702.7
Molecular Formula
C29H41N8O9F3
Targets
αvβ3 Receptor (Cell-free assay): 4.1 nM; αvβ5 Receptor (Cell-free assay): 79 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 89 mg/mL (126.66 mM); Water: 7 mg/mL (9.96 mM); Ethanol: insoluble
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Cilengitide trifluoroacetate is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of various cancers by inhibiting integrin-mediated cell adhesion and tumor angiogenesis.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.